Ailin Lepletier

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity

Xian-Yang Li, Achim K. Moesta, Christos Xiao et al. · Cancer Discovery · 2019 · 256 citations · Full text

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan et al. · Immunity · 2020 · 169 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Activating Receptor Cd226 +9

CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function

Deepak Mittal, Ailin Lepletier, Jason Madore et al. · Cancer Immunology Research · 2019 · 111 citations · Full text

Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma

Ailin Lepletier, Jason Madore, Jake S. O’Donnell et al. · Clinical Cancer Research · 2020 · 107 citations · Full text

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

Xian-Yang Li, Indrajit Das, Ailin Lepletier et al. · Journal of Clinical Investigation · 2018 · 106 citations · Full text